$0.70 EPS Expected for Fresenius Medical Care AG & Co. KGaA (FMS); Clarivest Asset Management Has Decreased Allete (ALE) Holding

April 17, 2018 - By Nellie Frank

ALLETE, Inc. (NYSE:ALE) Logo

Clarivest Asset Management Llc decreased Allete Inc (ALE) stake by 35.42% reported in 2017Q4 SEC filing. Clarivest Asset Management Llc sold 27,700 shares as Allete Inc (ALE)’s stock declined 2.36%. The Clarivest Asset Management Llc holds 50,500 shares with $3.76 million value, down from 78,200 last quarter. Allete Inc now has $3.78 billion valuation. The stock increased 0.84% or $0.615 during the last trading session, reaching $73.755. About 22,999 shares traded. ALLETE, Inc. (NYSE:ALE) has risen 5.24% since April 17, 2017 and is uptrending. It has underperformed by 6.31% the S&P500.

Analysts expect Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to report $0.70 EPS on May, 3 after the close.They anticipate $0.17 EPS change or 32.08% from last quarter’s $0.53 EPS. FMS’s profit would be $429.24 million giving it 18.63 P/E if the $0.70 EPS is correct. After having $0.69 EPS previously, Fresenius Medical Care AG & Co. KGaA’s analysts see 1.45% EPS growth. The stock increased 2.03% or $1.04 during the last trading session, reaching $52.17. About 77,886 shares traded. Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has risen 18.90% since April 17, 2017 and is uptrending. It has outperformed by 7.35% the S&P500.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. The company has market cap of $31.99 billion. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. It has a 20.39 P/E ratio. The firm also develops, makes, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, and endovascular specialty, as well as hospitalist and intensivist, and medical cost management services.

Among 8 analysts covering Fresenius Medical (NYSE:FMS), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Fresenius Medical had 17 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was upgraded by Goldman Sachs on Thursday, September 3 to “Buy”. The rating was maintained by RBC Capital Markets with “Hold” on Tuesday, May 30. The rating was maintained by RBC Capital Markets on Thursday, November 2 with “Hold”. The rating was maintained by SunTrust with “Buy” on Thursday, November 2. As per Thursday, March 17, the company rating was initiated by Nomura. The firm has “Hold” rating by RBC Capital Markets given on Thursday, October 12. The firm earned “Hold” rating on Friday, July 8 by Jefferies. The stock of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has “Sector Perform” rating given on Wednesday, November 4 by RBC Capital Markets. The firm has “Hold” rating by RBC Capital Markets given on Monday, September 11. The rating was maintained by RBC Capital Markets with “Hold” on Wednesday, July 5.

Investors sentiment increased to 1.29 in 2017 Q4. Its up 0.31, from 0.98 in 2017Q3. It is positive, as 14 investors sold ALE shares while 75 reduced holdings. 41 funds opened positions while 74 raised stakes. 35.80 million shares or 1.23% less from 36.24 million shares in 2017Q3 were reported. Qs Ltd Limited Liability Company accumulated 81,166 shares. Savings Bank Of Montreal Can, Ontario – Canada-based fund reported 2,402 shares. Vident Advisory stated it has 0.02% in ALLETE, Inc. (NYSE:ALE). Great West Life Assurance Com Can has invested 0.01% in ALLETE, Inc. (NYSE:ALE). Stratos Wealth Prns Ltd accumulated 479 shares. Glenmede Trust Na reported 415,529 shares. Royal Bancorporation Of Canada holds 46,070 shares or 0% of its portfolio. Creative Planning owns 14,265 shares. Everence Capital Management, Indiana-based fund reported 3,670 shares. Logan Capital Mngmt has invested 0.13% in ALLETE, Inc. (NYSE:ALE). Deroy And Devereaux Private Invest Counsel invested in 1.59% or 202,599 shares. Hgk Asset Mngmt reported 5,285 shares or 0.05% of all its holdings. Swiss Natl Bank has invested 0.01% of its portfolio in ALLETE, Inc. (NYSE:ALE). Financial Bank Of America De has 0% invested in ALLETE, Inc. (NYSE:ALE). Ahl Limited Liability Partnership owns 73,374 shares for 0.09% of their portfolio.

Among 9 analysts covering ALLETE Inc (NYSE:ALE), 2 have Buy rating, 1 Sell and 6 Hold. Therefore 22% are positive. ALLETE Inc had 20 analyst reports since October 15, 2015 according to SRatingsIntel. JP Morgan maintained the shares of ALE in report on Wednesday, March 30 with “Underweight” rating. Williams Capital Group maintained it with “Buy” rating and $75 target in Friday, April 21 report. JP Morgan maintained it with “Underweight” rating and $64 target in Friday, March 16 report. The rating was upgraded by Wunderlich to “Buy” on Tuesday, December 8. The company was initiated on Friday, November 4 by Macquarie Research. The stock of ALLETE, Inc. (NYSE:ALE) earned “Hold” rating by Williams Capital Group on Thursday, October 12. The rating was maintained by JP Morgan on Thursday, October 12 with “Underweight”. The firm has “Hold” rating given on Friday, October 20 by Ladenburg. The firm has “Underweight” rating by JP Morgan given on Thursday, January 25. The stock of ALLETE, Inc. (NYSE:ALE) has “Hold” rating given on Tuesday, January 2 by Guggenheim.

Clarivest Asset Management Llc increased Radnet Inc (NASDAQ:RDNT) stake by 37,200 shares to 124,305 valued at $1.26 million in 2017Q4. It also upped Pepsico Inc (NYSE:PEP) stake by 121,200 shares and now owns 564,542 shares. Alphabet Inc was raised too.

Since March 26, 2018, it had 0 buys, and 1 sale for $56,408 activity. On Monday, March 26 the insider Hoolihan James J sold $56,408.

ALLETE, Inc. (NYSE:ALE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: